Skip to main navigation
Arvinas logo
Search
Close
Arvinas logo
Search
Close

Investors and Media

Financials & SEC Filings

Annual Reports
2021 Annual Report
2020 Annual Report
2019 Annual Report

Proxy Statements

Filing date View
Apr 27, 2022 View HTML
0001655759-22-000006.pdf
0001655759-22-000006.rtf
0001655759-22-000006.xls
Apr 26, 2021 View HTML
0001564590-21-020535.pdf
0001564590-21-020535.rtf
0001564590-21-020535.xls

Form 10-K

Filing date View
Feb 28, 2022 View HTML
0001628280-22-004262.pdf
0001628280-22-004262.rtf
0001628280-22-004262.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Mar 01, 2021 View HTML
0001564590-21-009857.pdf
0001564590-21-009857.rtf
0001564590-21-009857.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA

Form 10-Q

Filing date View
Nov 09, 2022 View HTML
0001655759-22-000054.pdf
0001655759-22-000054.rtf
0001655759-22-000054.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Aug 04, 2022 View HTML
0001655759-22-000027.pdf
0001655759-22-000027.rtf
0001655759-22-000027.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA

All SEC Filings

There are no SEC filings available.
  • First page « First
  • Previous page ‹ Previous
  • Page 1
  • Current page 2
Displaying 11 - 13 of 13 results

Data provided by Kaleidoscope.

  • Print Page
    Print Page
  • RSS Feeds
    RSS Feeds
  • Email Alerts
    Email Alerts
  • Search
    Search
Arvinas logo
  • Careers
  • Privacy Policy
  • Terms of Use
Menu
  • Careers
  • Privacy Policy
  • Terms of Use
Linkedin-in Twitter

© 2023 Arvinas. All rights reserved.

Arvinas logo
Search
Close
  • Our Science
    • PROTAC® Discovery Engine
    • Scientific Publications
    • Partnerships
  • About Us
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
  • Research & Development
    • Pipeline
    • Androgen Receptor
    • Estrogen Receptor
    • Nueroscience
  • Careers & Culture
    • Open Positions
    • Life in the Haven
    • Our Values
    • Benefits
    • Giving Back
  • Patients
    • Patients with Breast Cancer
    • Patients with Prostate Cancer
    • Clinical Trials
    • Expanded Access Policy
  • Investors & Media
    • Press Releases
    • Events & Presentations
    • Corporate Governance
    • Financials & SEC Filings
    • Annual Meeting
    • Stock Information
    • Analyst Coverage
    • Investor FAQs
    • Resources
    • Email Alerts
  • Contact Us
Menu
  • Contact Us
Linkedin-in Twitter